Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.
Frequently asked questions
What sector does Tharimmune Inc. (THAR) operate in?
Tharimmune Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Tharimmune Inc. (THAR) current stock price?
As of the latest data, Tharimmune Inc. stock price is $3.31, with a previous close of $3.31.
What is Tharimmune Inc. (THAR) current market capitalization?
Tharimmune Inc. market cap is approximately 130.84 million.
What is Tharimmune Inc. (THAR) Earnings Per Share (EPS)?
The trailing EPS is -$3.68.
Does Tharimmune Inc. (THAR) pay dividends?
No. Tharimmune Inc. does not pay a dividend.
What is Tharimmune Inc. (THAR) beta (volatility) score?
Tharimmune Inc. has a beta of 1.453, suggesting it is more volatile than the market.